Mariana Brandão

16PUBLICATIONS
147CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 10, 2026
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

|Apr 07, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Arianna Marinello, Julia K Rotow, Meghanne Lomibao

|Mar 31, 2026
Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

Abdullah Mayet, Beatrice Parma, Déborah Lécuyer

|Jan 21, 2025
De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence?

Jordi Remon, Martina Bortolot, Paolo Bironzo

|Oct 01, 2024
Response to letter "re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: A nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB)".

Diogo Martins-Branco, Mariana Brandão, Evandro de Azambuja

|Aug 10, 2024
What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.

Julio Linares Díaz, John Edwards, Anne-Leen Deleu

Pageof 3

Frequent Collaborators

6 joint publications

Evandro de Azambuja

4 joint publications

Martine Piccart-Gebhart

4 joint publications

Diogo Martins-Branco

4 joint publications

Matteo Lambertini